Global Heart Failure Drugs Market Industry Analysis, Size, Share and Growth Trends 2020-2026
Summary - A new market study, titled “Global Heart Failure Drugs Market Research Report—Forecast till 2025” has been featured on WiseGuyReports.
Global Heart Failure Drugs Market Research
Report—Forecast till 2025
Market Overview
The Global Heart Failure Drugs Market is
expected to register a CAGR of 17.79% to reach USD 13,069.75 Million during the
review period. Heart failure is considered a chronic disease it causes because
of the improper working of heart muscles. In this disease, the heart muscle is
unable to pump a sufficient amount of blood to the body’s requirement due to
which patient causes fatigue and shortness of breath and sometimes results in a
cough.
The increasing prevalence of cardiovascular
disorders, rising geriatric population, and the adoption of changing lifestyle
habits like unhealthy dietary habits, excessive alcohol consumption, smoking,
obesity, and lack of physical activity attribute the growth of the global
market. However, a strong pipeline and product approvals are also propelling
market growth. Furthermore, the serious side-effects of such drugs can hinder
the growth of the global market.
Market Segmentation
The Global Heart Failure Drugs Market has
been classified based on, and end-user. The market, by type, has been further
segmented into Beta-Blockers, ACE Inhibitors, Angiotensin-Receptor Neprilysin
Inhibitors (ARNI), Angiotensin Receptor Blockers (ARBs), Diuretic, and others.
The global heart failure drugs market, by end-user, has been categorized as
hospitals, specialty centers, and others.
Regional Analysis
The geographical analysis of global
reference check software market spans across North America, Europe,
Asia-Pacific, the Middle East, and Africa.
In 2018 the Americas were the largest
market for heart failure drugs and it is expected to command the market during
the forecast period. The regional market growth is driven by the increasing
rate of cardiovascular disorders, increasing healthcare expenditure, and
growing obesity cases. Furthermore, the adoption of modern lifestyle habits
such as unhealthy dietary habits, regular alcohol consumption, smoking,
obesity, and lack of physical workouts are making individuals more susceptible
to arrhythmia and heart failure and are driving the market growth.
Europe is anticipated as the second-largest
market for heart failure owing to increasing cardiovascular disorders and
rising cigarette smoking population. Western Europe, is dominating the regional
market.
Asia-Pacific is evaluated to exhibit the
fastest-growing market during the review period owing to the increasing patient
pool and rising technological advancements. Furthermore the rising per capita
expenditure along with government initiatives to enhance the quality of
healthcare and rising cardiovascular diseases being the major concern in this
region and attributes to the market growth. The Middle East & Africa
exhibits the limited growth in the evaluation period, the regional market of
heart failure drugs is propelled by increasing obesity issues, rising
initiatives by governments to improve patient care, and favorable reimbursement
policies.
Major Players
The key players in the global heart failure
drugs market are Amgen Inc. (US), AstraZeneca (UK), Novartis AG (Switzerland),
Boehringer Ingelheim International GmbH (Germany), Johnson & Johnson
Services, Inc. (UK), Bristol-Myers Squibb Company (US), Merck Sharp & Dohme
Corp. (US), Pfizer, Inc. (US), Gilead Sciences, Inc. (California), and others.
We are continuously tracking the impact of COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations and many other useful insights.
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/5415382-global-heart-failure-drugs-market-research-report-forecast-till-2025
About
Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact
Us:
NORAH TRENT
sales@wiseguyreports.com
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)
Comments
Post a Comment